Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy

Epilepsia

Volumn 39, Issue 7, 1998, Pages 799-803

  Chadwick, D ^a   Beghi, E ^b   Callaghan, N ^b   de Bittencourt, P ^b   Dulac, O ^b   Gram, L ^b   Johnson, A L ^b   Mattson, R ^b   Pisani, F ^b   Porter, R J ^b   Richens, A ^b   Schmidt, D ^b   van Donselaar, C A ^b  

^a WALTON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ANTICONVULSANT THERAPY; ARTICLE; CLINICAL PROTOCOL; CLINICAL RESEARCH; DRUG RESEARCH; EPILEPSY; PATIENT SELECTION; PRIORITY JOURNAL;

ANTICONVULSANTS; CHRONIC DISEASE; CLINICAL TRIALS; DRUG APPROVAL; EPILEPSY; GUIDELINES; HUMANS; PRODUCT SURVEILLANCE, POSTMARKETING; RESEARCH DESIGN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0031873690     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01167.x     Document Type: Article

References (16)

1. Guidelines for the Clinical Evaluation of Antiepileptic Drugs. Epilepsia 1989;30:400-6.
2. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures. N Eng J Med 1985; 313:145-51.
3. Mattson RH, Cramer JA, Collins JF, et al. A comparison of valproate with carbamazepine for the treatment of complex partial seizures with secondary generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:765-71.
4. Jacoby A. Assessing quality of life in patients with epilepsy. PharmacoEconomics 1996;9:399-416.
5. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
6. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
7. Johnson T. Statistical methods and clinical trials. In: Freeman C, Tyrer P, eds. Research methods in psychiatry: a beginner's guide, 2nd ed. London: Royal College of Psychiatrists, 1992.
8. Heller AJ, Stewart J, Hughes E, et al. Comparative efficacy and toxicity of phenobarbital, phenytoin, carbamazepine and valproate in adults and children with newly diagnosed previously untreated epilepsy. J Neurol Neurosug Psychiatry 1995;58:44-50.
9. Jones B, Jarvis P, Lewis JA, et al. Trials to assess equivalence: the importance of rigorous methods. Br Med J 1996;313:36-9.
10. Henry D, Hill S. Comparing treatments. Comparison should be against active treatments rather than placebos. Br Med J 1995;310: 1279.
11. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994;331:394-8.
12. Temple R. Government viewpoint on clinical trials. Drug Info J 1982;1:10-7.
13. Hill AB. Medical ethics and controlled trials. Br Med J 1963;1: 1043-9.
14. Leber P. Hazards of inference: the active control investigation. Epilepsia 1989;30 (suppl 1):S57-63.
15. Marson AG, Beghi E, Berg A, Chadwick D, Tonini C. The Cochrane collaboration: systematic reviews and their relevance to epilepsy.
16. Richens A. Rational polypharmacy. Seizure 1995;4:211-4.